OUTSMART HF:非缺血性心衰中常规与选择性心脏磁共振的随机对照试验
本研究将500例非缺血性心衰患者随机分为常规CMR策略组与选择性CMR策略组,比较3个月时临床评估的具体心衰病因检出率。结果显示两组具体病因检出率无显著差异(44%对50%,P=0.22),影像判读的具体病因率亦无差异(34%对30%,P=0.34)。基于影像分类的具体病因患者临床事件更多(19%对12%,P=0.02),而临床评估定义的具体病因则无此差异。
要点
- 常规CMR未提高非缺血性心衰的具体病因检出率。
- 选择性组24%患者接受了非方案CMR,可能稀释策略差异。
- 影像判读的具体病因与更多临床事件相关,临床评估则否。
核心结论
- 在非缺血性心衰患者中,常规CMR策略并未在临床评估上获得更多具体心衰病因。
- 基于影像分类的具体心衰病因患者临床事件更多,而基于临床评估定义的具体病因则无此关联。
研究设计与样本
- 随机对照试验,共纳入500例非缺血性心衰患者(男性344例),平均年龄59±13岁。
- 患者随机接受常规CMR策略(超声心动图+CMR)或选择性CMR策略(超声心动图,根据临床表现决定是否加做CMR)。
- 主要结局为3个月时临床评估的具体心衰病因;临床事件收集12个月。
主要发现
- 3个月临床随访时,常规组与选择性组具体心衰病因率分别为44%与50%(P=0.22)。
- 影像判读时,常规组与选择性组具体心衰病因率分别为34%与30%(P=0.34)。
- 选择性组中24%的患者接受了非方案CMR。
- 影像分类的具体病因患者临床事件发生率为19%,非具体病因者为12%(P=0.02)。
- 临床评估的具体病因患者临床事件发生率为15%,非具体病因者为14%(P=0.49)。
临床怎么用
- 对于非缺血性心衰患者,不必常规加做CMR,可根据临床表现选择性使用。
- 影像判读发现的具体病因可能提示更高临床事件风险,需加强监测。
局限性
- 选择性组中24%患者接受了非方案CMR,可能影响策略间比较。
- 具体心衰病因的临床评估与影像判读一致性可能影响结果解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiac magnetic resonance (CMR) is a recommended imaging test for patients with heart failure (HF); however, there is a lack of evidence showing incremental benefit over transthoracic echocardiography. Our primary hypothesis was that routine use of CMR will yield more specific diagnoses in nonischemic HF. Our secondary hypothesis was that routine use of CMR will improve patient outcomes. METHODS: Patients with nonischemic HF were randomized to routine versus selective CMR. Patients in the routine strategy underwent echocardiography and CMR, whereas those assigned to selective use underwent echocardiography with or without CMR according to the clinical presentation. HF causes was classified from the imaging data as well as by the treating physician at 3 months (primary outcome). Clinical events were collected for 12 months. RESULTS: A total of 500 patients (344 male) with mean age 59±13 years were randomized. The routine and selective CMR strategies had similar rates of specific HF causes at 3 months clinical follow-up (44% versus 50%, respectively; P=0.22). At image interpretation, rates of specific HF causes were also not different between routine and selective CMR (34% versus 30%, respectively; P=0.34). However, 24% of patients in the selective group underwent a nonprotocol CMR. Patients with specific HF causes had more clinical events than those with nonspecific caused on the basis of imaging classification (19% versus 12%, respectively; P=0.02), but not on clinical assessment (15% versus 14%, respectively; P=0.49). CONCLUSIONS: In patients with nonischemic HF, routine CMR does not yield more specific HF causes on clinical assessment. Patients with specific HF causes from imaging had worse outcomes, whereas HF causes defined clinically did not. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01281384.
引用
- Paterson DI, Wells G, Erthal F, et al. OUTSMART HF: A Randomized Controlled Trial of Routine Versus Selective Cardiac Magnetic Resonance for Patients With Nonischemic Heart Failure (IMAGE-HF 1B). Circulation. 2020. PMID: 31910649. doi:10.1161/CIRCULATIONAHA.119.043964
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。